BTIG Maintains Buy on BrightSpring Health, Raises Price Target to $65

Benzinga Newsdesk www.benzinga.com Positive 71.3%

Neg 0% Neu 0% Pos 71.3%

BTIG analyst David Larsen maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the price target from $55 to $65.